A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation
Clinical trial NCT04973163 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04973163
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2026-11-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.